All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
IBB real return snapshot: after CPI-U inflation, IBB returned +42.43% over the past year and +20.70% YTD, with dividends reinvested. Since Feb. 9, 2001, IBB is up +241.51% in real purchasing-power return, or +4.91%/yr, and is currently −3.29% below its real total-return high on Feb. 8, 2021.
Data ending Tue Sep. 22, 2026
| Fri 2001-02-09💬 to Tue 2026-09-22 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| IBB × |
+241.51%
+4.91%/yr |
+8.00%/yr
R2=0.801 |
||||
| iShares Biotechnology ETF NASDAQ Exchange-Traded Fund | ||||||
| Fri 2001-02-09💬 to Tue 2026-09-22 |
Start
Value |
End
Value |
|---|---|---|
| IBB × |
$10,000.00
2001-02-09 |
$34,150.78
2026-09-22 |
| YTD | YoY | |
|---|---|---|
| IBB × | +20.70% | +42.43% |
|
Current
Drawdown |
Worst
Drawdown |
|
|---|---|---|
| IBB × |
−3.29%
on 2026-09-22 from 2021-02-08 peak |
−63.31%
on 2002-07-10 from 2001-06-05 peak |
| Period ending Tue 2026-09-22 | 1 yr | 2 yr | 3 yr | 5 yr | 10 yr |
|---|---|---|---|---|---|
| IBB × | +42.43% |
+34.46% +15.96%/yr |
+58.96% +16.71%/yr |
+1.67% +0.33%/yr |
+55.45% +4.51%/yr |
| Year | IBB |
|---|---|
| 2026 (YTD) | +20.70% |
| 2025 | +24.65% |
| 2024 | −5.14% |
| 2023 | +0.40% |
| 2022 | −18.93% |
| 2021 | −5.69% |
| 2020 | +24.32% |
| 2019 | +22.62% |
| 2018 | −11.22% |
| 2017 | +18.57% |
| 2016 | −23.01% |
| 2015 | +10.75% |
| 2014 | +32.83% |
| 2013 | +63.09% |
| 2012 | +29.88% |
| 2011 | +8.49% |
| 2010 | +13.15% |
| 2009 | +12.12% |
| 2008 | −12.36% |
| 2007 | +0.41% |
| 2006 | −1.80% |
| 2005 | −0.95% |
| 2004 | +1.49% |
| 2003 | +43.11% |
| 2002 | −47.06% |
| 2001 | −10.60% |
